Roundup Glyphosate Non-Hodgkin Lymphoma
Claims open now
Mass-tort payouts ($50k+)
mass_tort · pharma
Roundup glyphosate Non-Hodgkin lymphoma settlements - Bayer paying claims
Eligibility hint
Used Roundup regularly (commercially or as a homeowner) and were diagnosed with Non-Hodgkin lymphoma, CLL, or related blood cancers
Bayer (which acquired Monsanto) has paid over $10 billion in Roundup settlements alleging the glyphosate-based herbicide causes Non-Hodgkin lymphoma. Additional rounds of settlements continue for newly-diagnosed plaintiffs. Eligibility centers on documented Roundup use (commercial or residential) and a qualifying lymphoma diagnosis.
Recent signals
- Judge declares mistrial in Roundup lawsuit after US Supreme Court ruling - The Business Journals
- Bayer’s Supreme Court Win in Roundup Case No ‘Silver Bullet’ - Claims Journal
- CL filing: Utu Utu Gwaitu Paiute Tribe of the Benton Paiute Reservation v. United States Department of the Interior
- Bayer creates new unit for Roundup business, based in Creve Coeur - The Business Journals
- A murder arrest, salmon reintroduced at Mount St. Helens among TNT’s top stories - Tacoma News Tribune
- CL filing: Utu Utu Gwaitu Paiute Tribe of the Benton Paiute Reservation v. United States Department of the Interior
- Judge delays Bayer's $7.25B Roundup settlement hearing amid objections - The Business Journals
- Bayer's $7.25 billion Roundup settlement gets August hearing date - Reuters
- What the Supreme Court’s Decision Means for the Future of Roundup Lawsuits - Consumer Notice
- Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller - PBS
Brands:
monsantobayer
Products: roundupglyphosateranger pro
Products: roundupglyphosateranger pro
Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.